Less Ads, More Data, More Tools Register for FREE

Pin to quick picksGraphene Nanochem Regulatory News (GRPH)

  • There is currently no data for GRPH

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Senior Management Appointment

3 Dec 2013 07:00

RNS Number : 4963U
Graphene NanoChem PLC
03 December 2013
 

 

3 December 2013

 

Graphene NanoChem plc

("Graphene NanoChem" or the "Group")

Appointment of Chief Chemicals Officer and Acquisition of Nanomaterials Technology

Graphene NanoChem (AIM: GRPH), the performance nanochemicals and advanced materials company, is pleased to announce the appointment of Dr. Yinan Jin as Chief Chemicals Officer. Dr. Yinan Jin will be heading the nanomaterials production unit and will be responsible for developing product application opportunities in chemicals and catalysis.

Graphene NanoChem is also pleased to announce the acquisition of a carbon nanotube technology and new catalyst formulations, as well as the acquisition of technology relating to the production of chemicals additives with applications in the oilfield chemicals market, all developed by Dr. Yinan Jin.

Dr. Yinan Jin is a chemical synthesis expert experienced in the commercial production of nanomaterials and developing industrial chemical compounds and solutions. He was the project leader of the pioneering team that built and operated the first ground-breaking nanomaterials facility in Burnaby, Canada, on which Graphene NanoChem's original technology was based.

His appointment is the latest in a series of steps taken by Graphene NanoChem to scale up operations at the nanomaterials facility and to further the development of applications. Through the acquisition and technology transfer arrangement, Graphene NanoChem and Dr. Yinan Jin will combine their innovative technologies and expertise to develop market leading solutions in nanofluid applications for oilfield chemicals, lubricants and catalysis.

Graphene NanoChem is focused on expanding its graphene-enhanced chemicals portfolio. Tests have indicated that incorporating nanomaterials in chemicals fluids for these applications delivers a range of performance enhancements, from friction and wear reduction to energy and efficiency enhancements which translate to significant cost reduction and performance benefits such as enhancing machinery operations, improving operational efficiency and extending the life of fluids and machinery. In catalysis, the addition of graphene improves performance and enhances yield, thereby driving down production costs for customers.

Jespal Deol, Chief Executive Officer of Graphene NanoChem commented: "On behalf of Graphene NanoChem, I am delighted to welcome Dr. Yinan Jin to our team. The acquisition of the nanomaterial technologies combined with Dr. Yinan Jin's practical, results and market-oriented approach in technology innovation and applications development will significantly expand our intellectual property, which in turn enhances our products portfolio allowing for wider range of opportunities in applications.

"We look forward to working with Dr. Yinan Jin going forward to accelerate the development of our graphene-enhanced chemicals portfolio as well as our specialty chemicals business."

 

For further information:

Graphene NanoChem

Tel: +603 2282 3080

Jespal Deol, Chief Executive Officer

Panmure Gordon (NOMAD and Broker)

Callum Stewart / Atholl Tweedie

Tel: +44 (0) 20 7886 2500

Tom Nicholson

Tel: +65 8614 7553

Buchanan

Tel: +44 (0) 20 7466 5000

Mark Edwards / Fiona Henson / Helen Greenwood

 

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
MSCBRBDDUGGBGXD
Date   Source Headline
5th Dec 20062:39 pmRNSHolding(s) in Company
1st Dec 20062:48 pmRNSHolding(s) in Company
30th Nov 20069:20 amRNSHolding(s) in Company
29th Nov 200612:07 pmRNSHolding(s) in Company
23rd Nov 20061:43 pmRNSEGM Statement
21st Nov 20067:00 amRNSChange of Registered Address
2nd Nov 200612:33 pmRNSDirector/PDMR Shareholding
1st Nov 20062:10 pmRNSDirector/PDMR Shareholding
1st Nov 200611:40 amRNSSchedule 1 - Biofutures Int
30th Oct 20067:01 amRNSAcquisition
30th Oct 20067:01 amRNSRestoration - Biofutures Intl
22nd Sep 20067:00 amRNSMaiden Interim Results
25th Aug 20063:00 pmRNSAppt. of Finance Director
28th Jul 20062:43 pmRNSConditional Agreement
19th Jun 20069:56 amRNSHolding(s) in Company
1st Jun 200611:45 amRNSSuspension - Biofutures Intl
1st Jun 200611:45 amRNSre Press Speculation
24th May 20063:08 pmRNSHolding(s) in Company
24th May 20067:01 amRNSHolding(s) in Company
17th May 20062:45 pmRNSHolding(s) in Company
17th May 200610:19 amRNSHolding(s) in Company
15th May 200611:38 amRNSHolding(s) in Company
15th May 200610:56 amRNSHolding(s) in Company
11th May 200612:10 pmRNSHolding(s) in Company
5th May 20061:39 pmRNSDirector shareholding
5th May 200611:10 amRNSHolding(s) in Company
5th May 20069:00 amRNSPlacing & Admission to AIM

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.